AAHP Successfully Works with FDA to Resolve Drug Listing Issue
The AAHP established a homeopathic Drug Listing SPL Sub-Team to work with FDA’s Electronic Drug Listing group to address some of the unique challenges faced by homeopathic drug companies in complying with the requirements for electronic registrations.
Regulation of Homeopathic Drug Products
The regulation of homeopathic drug products is discussed.
- « Previous
- 1
- …
- 6
- 7
- 8
AAHP monitors and reports on current federal regulations, legislation and government policies that affect the homeopathic community. AAHP is often the first to learn of regulatory changes that have both direct and indirect effects on our industry enabling members to stay ahead of the curve in a rapidly changing healthcare environment.